Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry.

Sebastian Völz,Petur Petursson,Jacob Odenstedt,Dan Ioanes,Inger Haraldsson,Oskar Angerås,Christian Dworeck,Geir Hirlekar,Anna Myredal,Per Albertsson,Truls Råmunddal,Björn Redfors,Elmir Omerovic

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry.

2020

Sebastian Völz
Petur Petursson
Jacob Odenstedt
Dan Ioanes
Inger Haraldsson
Oskar Angerås
Christian Dworeck
Geir Hirlekar
Anna Myredal
Per Albertsson
Truls Råmunddal
Björn Redfors
Elmir Omerovic

Background Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with ...

Keywords:

Angioplasty
Internal medicine
Acute coronary syndrome
Percutaneous coronary intervention
Ticagrelor
Clopidogrel
Conventional PCI
Unstable angina
Medicine
Cardiology
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations